[ad_1]
Large-scale inoculation centers installed from the second week of January
Easier to store than Pfizer, making it easy to distribute
▲ A candidate material for a new vaccine against coronavirus infection (Corona 19) jointly developed by AstraZeneca and the University of Oxford. The UK government plans to distribute the AstraZeneca vaccine from the 4th of next month (local time). Reuters Yonhap News
The UK government will distribute a new vaccine against coronavirus infection (Corona 19) developed by AstraZeneca and the University of Oxford on the 4th of next month. AstraZeneca is expected to be easily distributed because it is easy to store.
According to the British Guardian on the 26th (local time), the UK Medicines and Healthcare Products Regulatory Authority (MHRA) plans to approve the use of the AstraZeneca vaccine within a few days. If approval is granted, large-scale vaccination stations will be installed in sports arenas and conference halls starting the second week of January next year. The UK government is planning the first dose of the AstraZeneca vaccine or the Pfizer-Bioentech vaccine, targeting 2 million people in two weeks.
A government spokesperson said, “Pharmaceutical regulators are reviewing the final data from AstraZeneca’s phase 3 clinical trials to ensure that the quality and efficacy of the vaccine meet standards,” he said. “We need to give regulators time to do the job.” said. A government official said on the 27th that MHRA approval could be withdrawn as soon as possible.
AstraZeneca submitted the data for its emergency use approval on the 21st. It is reported that the MHRA also held deliberations during the Christmas holidays.
The AstraZeneca vaccine is expected to be easier to distribute because it is easier to store than the Pfizer vaccine. The biggest weakness of the Pfizer vaccine is that it must be stored at an extremely low temperature of -70 ° C. It can only be stored for 5 days at the standard refrigeration temperature of 2 ~ 8 ℃. AstraZeneca, on the other hand, can be stored for 6 months at standard refrigerated temperatures.
Meanwhile, the UK officially started the first vaccination on Day 8 after approving the world’s first Pfizer vaccine on Day 2. However, the emergence of a virus variant that is at least 56% more contagious than the Corona virus 19 existing is suffering from headaches.
In response, AstraZeneca is confident that its vaccine will be effective against the variant of the virus. Pascal Sorio AstraZeneca, CEO of AstraZeneca, said: “More evidence will be needed to confirm (the actual effect), but we have found a formula to increase the efficacy of the vaccine.”
